Docs Show AstraZeneca Knew Of Seroquel Risks

Law360 (March 2, 2009, 12:00 AM EST) -- Court documents unsealed Friday indicate that AstraZeneca Pharmaceuticals LP officials were mulling concerns as long as a decade ago that the company's blockbuster anti-psychotic medication Seroquel could lead to weight gain and diabetes, with one memo lauding the project physician's “great 'smoke-and-mirrors' job!"

The documents were made public in the U.S. District Court for the Middle District of Florida after plaintiffs in a multidistrict litigation accusing AstraZeneca of failing to warn of Seroquel's potential health risks won their request to force the company to release all...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.